The role of herd immunity in control of measles.
Abstract
Measles vaccine cannot give high sero-conversion rates in developing countries. The high birth rates characteristic of these countries lead to infection at a very early age, thus making it difficult to vaccinate before exposure to the disease. Nevertheless, if given early in life, the vaccine can reduce the rate of virus circulation and thus raise the age at which children are infected. Once that is done, higher sero-conversion rates can be obtained by raising the age at vaccination. During the period when vaccine is given at an early age, the titers in responding children will be low, and this will leave children of the next generation with little protection. It is important, therefore, that if vaccine is used early the program be intensively and consistently applied to control virus circulation before the next generation is born.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (885K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Wilkins J, Wehrle PF, Portnoy B. Live, further attenuated rubella vaccine. Serologic responses among term and low birth weight infants. Am J Dis Child. 1972 Mar;123(3):190–192. [PubMed] [Google Scholar]
- Schluederberg A, Lamm SH, Landrigan PJ, Black FL. Measles immunity in children vaccinated before one year of age. Am J Epidemiol. 1973 Jun;97(6):402–409. [PubMed] [Google Scholar]
- Linnemann CC, Jr, Dine MS, Bloom JE, Schiff GM. Measles antibody in previously immunized children. The need for revaccination. Am J Dis Child. 1972 Jul;124(1):53–57. [PubMed] [Google Scholar]
- Deseda-Tous J, Cherry JD, Spencer MJ, Welliver RC, Boyer KM, Dudley JP, Zahradnik JM, Krause PJ, Walbergh EW. Measles revaccination. Persistence and degree of antibody titer by type of immune response. Am J Dis Child. 1978 Mar;132(3):287–290. [PubMed] [Google Scholar]
- Wilkins J, Wehrle PF. Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization. J Pediatr. 1979 Jun;94(6):865–869. [PubMed] [Google Scholar]
- Linnemann CC, Jr, Dine MS, Roselle GA, Askey PA. Measles immunity after revaccination: results in children vaccinated before 10 months of age. Pediatrics. 1982 Mar;69(3):332–335. [PubMed] [Google Scholar]
- Smith FR, Curran AS, Raciti KA, Black FL. Reported measles in persons immunologically primed by prior vaccination. J Pediatr. 1982 Sep;101(3):391–393. [PubMed] [Google Scholar]
- BLACK FL. Measles antibody prevalence in diverse populations. Am J Dis Child. 1962 Mar;103:242–249. [PubMed] [Google Scholar]
- van Mazijk J, Pinheiro FP, Black FL. Measles and measles vaccine isolated amerindian tribes. I. The 1971 Trio ((Tiriyo) epidemic. Trop Geogr Med. 1982 Mar;34(1):3–6. [PubMed] [Google Scholar]
- Baruzzi RG, Abdala N, Black FL. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic. Trop Geogr Med. 1982 Mar;34(1):7–12. [PubMed] [Google Scholar]
- DIXON FJ, TALMAGE DW, MAURER PH, DEICHMILLER M. The half-life on homologous gamma globulin (antibody) in several species. J Exp Med. 1952 May;95(5):313–318. [PMC free article] [PubMed] [Google Scholar]
Facebook
Twitter
Google+